Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for ...

Amgen's dividend yield remains attractive, with a moderate payout ratio and strong free cash flow. Click here to see why AMGN ...

Feb. 05, 2025 (GLOBE NEWSWIRE) -- In an industry-defining moment, Accumulus Synergy (“Accumulus”) has powered Amgen’s ...

With the overall stock market very overbought, the four highest-yielding Dogs of the Dow look like outstanding ideas now.

WESTLAKE VILLAGE, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage ...

EUR/USD: ECB May Signal Further Accommodative Monetary Policy Ahead By Kelvin Wong - Dec 06, 2024 Pronounced weakness in manufacturing activities in Germany may spread to the broader Eurozone.

Amazon and Google parent Alphabet are set to report earnings, along with other tech companies including AI darling Palantir, and chipmaker Advanced Micro Devices. Pharmaceutical firms Novo Nordisk, ...

Growth investors, on the other hand, are more concerned with a company's financial strength ... Thousand Oaks, CA-based Amgen is one of the biggest biotech companies in the world, with a strong ...

Amgen also has a growing biosimilar portfolio. Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a ...